Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. The ...

Figure 1: Antibody design to improve homogeneity ... Thus, decreasing costs is an important part of drug development. The IgG-based biotherapeutic agents that have been approved in the past ...

Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

The European Commission (EC) has approved catumaxomab, making it the only approved drug therapy for malignant ascites (MA) for patients living with this debilitating condition across Europe.

India's Contract Development and Manufacturing Organization (CDMO) market is poised for exponential growth, expected to ...

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...

Astellas has invested heavily in novel technologies that are not necessarily the most successful or popular in the industry.

Here is a look at Alzheimer’s disease, a progressive brain disorder that leads to loss of memory and other intellectual abilities. Facts Alzheimer’s disease is the most common form of dementia, which ...

Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

US biotech Abcuro has reeled in $200 million in third-round financing that should allow it to complete its pivotal trial of ...

The Scottish Medicines Consortium announced lecanemab would not be made available on the NHS, following a similar decision ...